COVID-19 Vaccine Update: Delhi’s LNJP Hospital To Get Three Lakh Doses

Around three lakh healthcare workers will get vaccine shots as PM Narendra Modi will virtually inaugurate the COVID-19 vaccination drive on January 16.

ZEE5 Web Desk

January 15, 2021

Trending News

3 min

zeenews

India’s COVID-19 vaccination drive will begin at Delhi’s LNJP hospital on 16 January. All preparations are done as PM will do a virtual inauguration of the nation-wide vaccination drive. On the first day, around 3 lakh healthcare workers will get vaccine shots at 2,934 sites across the country. In Delhi, as many as 100 people will be vaccinated at the first session, Delhi Chief Minister Arvind Kejriwal announced.

Watch the full story here:

In Delhi, the hospitals which will have daily vaccination sessions include AIIMS, Safdarjung Hospital, RML Hospital, Kalawati Saran Children Hospital, two ESI hospitals, LNJP Hospital, GTB Hospital, Rajiv Gandhi Super Speciality Hospital, DDU Hospital, BSA Hospital, Delhi State Cancer Institute, ILBS Hospital, and private facilities including Max Hospital, Fortis Hospital, Apollo Hospital and Sir Ganga Ram Hospital.

Addressing an online briefing, CM Arvind Kejriwal said the state government has received a total of 2.74 lakh doses of the vaccine so far from the Centre, which will be sufficiently catered to the 1.2 lakh healthcare workers in the capital. The first batch of Oxford Covishield vaccine containing 2.64 lakh doses was received at Delhi’s central storage facility at Rajiv Gandhi Super Speciality Hospital on Tuesday with a celebration.

Also read: First Batch Of SII’s Covishield Arrives In Mumbai, Ahead Of The Mass Vaccination Drive

Earlier, Kejriwal had done a review meeting on the vaccination rollout plan of the Delhi government before having a meeting with the centre. He informed that the stocks have been examined and the teams at work are ready for the COVID-19 vaccination sessions. The public including the frontline workers have been eagerly waiting for the programme to begin.

India’s drugs regulator has checked and approved Oxford’s Covishield vaccine, manufactured by the Serum Institute, along with the indigenously developed Covaxin of Bharat Biotech for emergency use in the country. Meanwhile, Delhi on Thursday recorded 340 new COVID cases as the positivity rate slipped to 0.48%.

For more COVID-19 related news, check out ZEE5.

Related Topics

Related News

More Loader